Mitochondrial oxidation of 4-hydroxy-2-nonenal in rat cerebral cortex

被引:33
|
作者
Murphy, TC
Amarnath, V
Picklo, MJ
机构
[1] Univ N Dakota, Dept Pharmacol Physiol & Therapeut, Sch Med & Hlth Sci, Grand Forks, ND 58203 USA
[2] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
关键词
Alzheimer's disease; 4-hydroxynonenal; aldehyde dehydrogenase; mitochondria;
D O I
10.1046/j.1471-4159.2003.01628.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
4-Hydroxy-trans-2-nonenal (HNE) is a neurotoxic product of lipid peroxidation whose levels are elevated in multiple neurodegenerative diseases and CNS trauma. The detoxification of HNE may take the route of glutathione conjugation to the C3 carbon and the oxidation or reduction of the C1 aldehyde. In this work, we examined whether the oxidation of HNE to its corresponding carboxylic acid, 4-hydroxy-trans-2-nonenoate (HNEAcid) was detoxifying event, if it occurred in rat cerebral cortex, and in which subcellular compartments. Our results show that HNEAcid did not form protein adducts and was non-toxic to Neuro 2A cells. HNEAcid formation occurred in rat cerebral cortex slices following exposure to HNE in a time-dependent and dose-dependent fashion. Homogenate studies indicated that HNEAcid formation was NAD(+) dependent. Subcellular fractionation demonstrated that mitochondria had the highest specific activity for HNEAcid formation with a K-M of 21 mum HNE. These data indicate that oxidation of HNE to its corresponding acid is a major detoxification pathway of HNE in the CNS and that mitochondria play a role in this process.
引用
收藏
页码:1313 / 1321
页数:9
相关论文
共 50 条
  • [41] Formation of 4-hydroxy-2-nonenal protein adducts in the ischemic rat heart after transplantation
    Renner, A
    Sagstetter, MR
    Harms, H
    Lange, V
    Götz, ME
    Elert, O
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (06): : 730 - 736
  • [42] Upregulation of γ-glutamyl transpeptidase by 4-hydroxy-2-nonenal in rat alveolar type II cells
    Zhang, HQ
    Dickinson, DA
    Liu, RM
    Forman, HJ
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S360 - S361
  • [43] Effects of covalentmodification by 4-hydroxy-2-nonenal on the noncovalent oligomerization of ubiquitin
    Grasso, Giuseppe
    Axelsen, Paul H.
    JOURNAL OF MASS SPECTROMETRY, 2017, 52 (01): : 36 - 42
  • [44] Novel Role of 4-Hydroxy-2-Nonenal Mediated Mitochondrial Stress Signaling in Ischemia and Reperfusion Injury
    Miriyala, Sumitra
    Chandra, Mini
    Panchatcharam, Manikandan
    Kevil, Christopher
    Bhuiyan, Md Shenuarin
    Fox, Jonathan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
  • [45] 4-hydroxy-2-nonenal is a powerful endogenous inhibitor of endothelial response
    Minekura, H
    Kumagai, T
    Kawamoto, Y
    Nara, F
    Uchida, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (02) : 557 - 561
  • [46] Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies
    Uchida, K
    Itakura, K
    Kawakishi, S
    Hiai, H
    Toyokuni, S
    Stadtman, ER
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 324 (02) : 241 - 248
  • [47] 4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease
    Montine, KS
    Kim, PJ
    Olson, SJ
    Markesbery, WR
    Montine, TJ
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (08): : 866 - 871
  • [48] INHIBITION OF THE MULTICATALYTIC PROTEASE BY 4-HYDROXY-2-NONENAL MODIFIED PROTEIN
    FRIGUET, B
    SZWEDA, LI
    STADTMAN, ER
    FASEB JOURNAL, 1994, 8 (07): : A1357 - A1357
  • [49] Possible involvement of 4-hydroxy-2-nonenal on development of leptin resistance
    Hosoi, Toru
    Kuwamura, Ayaka
    Ozawa, Koichiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S176 - S176
  • [50] Neuroprotectants from the lipid peroxidation product 4-hydroxy-2-nonenal
    Montine, T
    Neely, M
    Picklo, M
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (08) : S116 - S116